Dual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2077-2084

  Yu, Yung Luen ^a,b   Yiang, Giou Teng ^c,d   Chou, Pei Lun ^e,f   Tseng, Hsu Hung ^g   Wu, Tsai Kun ^a,h   Hung, Yu Ting ⁱ   Lin, Pei Shiuan ⁱ   Lin, Shu Yu ⁱ   Liu, Hsiao Chun ^c   Chang, Wei Jung ^a   Wei, Chyou Wei ⁱ  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c TAIPEI TZU CHI HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e Division of Nephrology   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g TAICHUNG HOSPITAL   (Taiwan)

^h TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

ⁱ HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Acetaminophen; Fibroblasts; Hepatoma; Kidney tubular cell

Indexed keywords

CASPASE 3; CASPASE 9; HYDROGEN PEROXIDE; PARACETAMOL;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; KIDNEY FIBROBLAST; KIDNEY FIBROSIS; KIDNEY TUBULE EPITHELIUM; LIVER CELL CARCINOMA; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; RAT; ANIMAL; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; EPITHELIUM CELL; KIDNEY; KIDNEY TUBULE; METABOLISM; TOXICITY; TUMOR CELL LINE;

ACETAMINOPHEN; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASE 9; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; KIDNEY; KIDNEY TUBULES; RATS;

EID: 84899672728     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2085     Document Type: Article

References (78)

1. Rumack BH: Acetaminophen misconceptions. Hepatology 40: 10-15, 2004.
2. Cuzzolin L, Antonucci R and Fanos V: Paracetamol (acetaminophen) efficacy and safety in the newborn. Curr Drug Metab 14: 178-185, 2013.
3. Klotz U: Paracetamol (acetaminophen) - a popular and widely used nonopioid analgesic. Arzneimittelforschung 62: 355-359, 2012.
4. Sullivan JE and Farrar HC; Section on Clinical Pharmacology and Therapeutics, Committee on Drugs: Fever and antipyretic use in children. Pediatrics 127: 580-587, 2011.
5. Young RJ: Dextropropoxyphene overdosage. Pharmacological considerations and clinical management. Drugs 26: 70-79, 1983.
6. Simkin S, Hawton K, Kapur N and Gunnell D: What can be done to reduce mortality from paracetamol overdoses? A patient interview study. QJM 105: 41-51, 2012.
7. Hawton K, Bergen H, Simkin S, et al: Impact of different pack sizes of paracetamol in the United Kingdom and Ireland on intentional overdoses: a comparative study. BMC Public Health 11: 460, 2011.
8. Hawton K, Townsend E, Deeks J, et al: Effects of legislation restricting pack sizes of paracetamol and salicylate on self poisoning in the United Kingdom: before and after study. BMJ 322: 1203-1207, 2001. (Pubitemid 32453064)
9. Daly FF, Fountain JS, Murray L, Graudins A and Buckley NA: Guidelines for the management of paracetamol poisoning in Australia and New Zealand - explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 188: 296-301, 2008.
10. Gopi KS, Reddy AG, Jyothi K and Kumar BA: Acetaminophen-in duced hepato- and nephrotoxicity and amelioration by silymarin and Terminalia chebula in rats. Toxicol Int 17: 64-66, 2010.
11. Abdel-Zaher AO, Abdel-Hady RH, Mahmoud MM and Farrag MM: The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. Toxicology 243: 261-270, 2008. (Pubitemid 50011452)
12. Cermik H, Taslipinar MY, Aydin I, et al: The relationship between N-acetylcysteine, hyperbaric oxygen, and inflammation in a rat model of acetaminophen-induced nephrotoxicity. Inflammation 36: 1145-1152, 2013.
13. Ucar F, Taslipinar MY, Alp BF, et al: The effects of N-acetylcysteine and ozone therapy on oxidative stress and inflammation in acetaminophen-induced nephrotoxicity model. Ren Fail 35: 640-647, 2013.
14. Liang YL, Zhang ZH, Liu XJ, et al: Melatonin protects against apoptosis-inducing factor (AIF)-dependent cell death during acetaminophen- induced acute liver failure. PLoS One 7: e51911, 2012.
15. Amaral SS, Oliveira AG, Marques PE, et al: Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity. Cell Commun Signal 11: 10, 2013.
16. Badmann A, Langsch S, Keogh A, Brunner T, Kaufmann T and Corazza N: TRAIL enhances paracetamol-induced liver sinusoidal endothelial cell death in a Bim- and Bid-dependent manner. Cell Death Dis 3: e447, 2012.
17. Badmann A, Keough A, Kaufmann T, Bouillet P, Brunner T and Corazza N: Role of TRAIL and the pro-apoptotic Bcl-2 homolog Bim in acetaminophen-induced liver damage. Cell Death Dis 2: e171, 2011.
18. McGill MR, Yan HM, Ramachandran A, Murray GJ, Rollins DE and Jaeschke H: HepaRG cells: a human model to study mechanisms of acetaminophen hepatotoxicity. Hepatology 53: 974-982, 2011.
19. Zhao X, Cong X, Zheng L, Xu L, Yin L and Peng J: Dioscin, a natural steroid saponin, shows remarkable protective effect against acetaminophen- induced liver damage in vitro and in vivo. Toxicol Lett 214: 69-80, 2012.
20. Mobasher MA, Gonzalez-Rodriguez A, Santamaria B, et al: Protein tyrosine phosphatase 1B modulates GSK3beta/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity. Cell Death Dis 4: e626, 2013.
21. Ramachandran A, McGill MR, Xie Y, Ni HM, Ding WX and Jaeschke H: Receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice. Hepatology 58: 2099-2108, 2013.
22. Ahmad ST, Arjumand W, Nafees S, et al: Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation. Toxicol Lett 208: 149-161, 2012.
23. Inkielewicz-Stepniak I and Knap N: Effect of exposure to fluoride and acetaminophen on oxidative/nitrosative status of liver and kidney in male and female rats. Pharmacol Rep 64: 902-911, 2012.
24. Slitt AM, Dominick PK, Roberts JC and Cohen SD: Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion. Basic Clin Pharmacol Toxicol 96: 487-494, 2005. (Pubitemid 40835705)
25. Yousef MI, Omar SA, El-Guendi MI and Abdelmegid LA: Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food Chem Toxicol 48: 3246-3261, 2010.
26. Zhang Y, Jia Y, Yang M, Yang P, Tian Y, Xiao A and Wen A: The impaired disposition of probe drugs is due to both liver and kidney dysfunctions in CCl(4)-model rats. Environ Toxicol Pharmacol 33: 453-458, 2012.
27. Zhao YL, Zhou GD, Yang HB, Wang JB, Shan LM, Li RS and Xiao XH: Rhein protects against acetaminophen-induced hepatic and renal toxicity. Food Chem Toxicol 49: 1705-1710, 2011.
28. Roomi MW, Kalinovsky T, Ivanov V, Rath M and Niedzwiecki A: A nutrient mixture prevents acetaminophen hepatic and renal toxicity in ICR mice. Hum Exp Toxicol 27: 223-230, 2008.
29. Posadas I, Santos P and Cena V: Acetaminophen induces human neuroblastoma cell death through NFKB activation. PLoS One 7: e50160, 2012.
30. Posadas I, Vellecco V, Santos P, Prieto-Lloret J and Cena V: Acetaminophen potentiates staurosporine-induced death in a human neuroblastoma cell line. Br J Pharmacol 150: 577-585, 2007. (Pubitemid 46355549)
31. Jaeschke H: Comments on 'glycogen synthase kinase-3 mediates acetaminophen-induced apoptosis in human hepatoma cells'. J Pharmacol Exp Ther 314: 1401-1404, 2005.
32. Macanas-Pirard P, Yaacob NS, Lee PC, Holder JC, Hinton RH and Kass GE: Glycogen synthase kinase-3 mediates acetaminophen-induced apoptosis in human hepatoma cells. J Pharmacol Exp Ther 313: 780-789, 2005. (Pubitemid 40604179)
33. Bilir A, Guneri AD and Altinoz MA: Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro. Neoplasma 51: 460-464, 2004. (Pubitemid 40052914)
34. Wu YJ, Neuwelt AJ, Muldoon LL and Neuwelt EA: Acetaminophen enhances cisplatin-and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma. Anticancer Res 33: 2391-2400, 2013.
35. Reszka KJ, Britigan LH, Rasmussen GT, Wagner BA, Burns CP and Britigan BE: Acetaminophen stimulates the peroxidative metabolism of anthracyclines. Arch Biochem Biophys 427: 16-29, 2004. (Pubitemid 38725910)
36. Manov I, Bashenko Y, Eliaz-Wolkowicz A, Mizrahi M, Liran O and Iancu TC: High-dose acetaminophen inhibits the lethal effect of doxorubicin in HepG2 cells: the role of P-glycoprotein and mitogen-activated protein kinase p44/42 pathway. J Pharmacol Exp Ther 322: 1013-1022, 2007. (Pubitemid 47295792)
37. Kidokoro K, Satoh M, Nagasu H, et al: Tacrolimus induces glomerular injury via endothelial dysfunction caused by reactive oxygen species and inflammatory change. Kidney Blood Press Res 35: 549-557, 2012.
38. Stacchiotti A, Li Volti G, Lavazza A, et al: Different role of Schisandrin B on mercury-induced renal damage in vivo and in vitro. Toxicology 286: 48-57, 2011.
39. Suddek GM: Sunitinib improves chemotherapeutic efficacy and ameliorates cisplatin-induced nephrotoxicity in experimental animals. Cancer Chemother Pharmacol 67: 1035-1044, 2011.
40. Neria F, Castilla MA, Sanchez RF, et al: Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity. Kidney Int 75: 227-234, 2009.
41. Jang HS, Kim JI, Jung KJ, Kim J, Han KH and Park KM: Bone marrow-derived cells play a major role in kidney fibrosis via proliferation and differentiation in the infiltrated site. Biochim Biophys Acta 1832: 817-825, 2013.
42. Seikrit C, Henkel C, van Roeyen CR, et al: Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts. Nephrol Dial Transplant 28: 889-900, 2013.
43. Kim SH, Yu MA, Ryu ES, Jang YH and Kang DH: Indoxyl sulfate-induced epithelial-to-mesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease. Lab Invest 92: 488-498, 2012.
44. Abdul Hamid Z, Budin SB, Wen Jie N, Hamid A, Husain K and Mohamed J: Nephroprotective effects of Zingiber zerumbet Smith ethyl acetate extract against paracetamol-induced nephrotoxicity and oxidative stress in rats. J Zhejiang Univ Sci B 13: 176-185, 2012.
45. Chen N, Aleksa K, Woodland C, Rieder M and Koren G: The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells. Transl Res 150: 51-57, 2007. (Pubitemid 46935594)
46. Isik B, Bayrak R, Akcay A and Sogut S: Erdosteine against acetaminophen induced renal toxicity. Mol Cell Biochem 287: 185-191, 2006. (Pubitemid 44057406)
47. Lorz C, Justo P, Sanz A, Subira D, Egido J and Ortiz A: Paracetamol-induced renal tubular injury: a role for ER stress. J Am Soc Nephrol 15: 380-389, 2004. (Pubitemid 38140778)
48. Lorz C, Justo P, Sanz AB, Egido J and Ortiz A: Role of Bcl-xL in paracetamol-induced tubular epithelial cell death. Kidney Int 67: 592-601, 2005. (Pubitemid 40139850)
49. Boulares AH, Zoltoski AJ, Stoica BA, Cuvillier O and Smulson ME: Acetaminophen induces a caspase-dependent and Bcl-XL sensitive apoptosis in human hepatoma cells and lymphocytes. Pharmacol Toxicol 90: 38-50, 2002. (Pubitemid 34165259)
50. Manov I, Hirsh M and Iancu TC: N-acetylcysteine does not protect HepG2 cells against acetaminophen-induced apoptosis. Basic Clin Pharmacol Toxicol 94: 213-225, 2004. (Pubitemid 38667867)
51. Manov I, Hirsh M and Iancu TC: Acetaminophen hepatotoxicity and mechanisms of its protection by N-acetylcysteine: a study of Hep3B cells. Exp Toxicol Pathol 53: 489-500, 2002. (Pubitemid 34204960)
52. Wu CS, Yen CJ, Chou RH, et al: Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma. PLoS One 7: e39466, 2012.
53. Yu YL, Su KJ, Chen CJ, et al: Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells. J Cell Physiol 227: 213-222, 2012.
54. Zhang L, Li J, Jiang Z, et al: Inhibition of aquaporin-1 expression by RNAi protects against aristolochic acid I-induced apoptosis in human proximal tubular epithelial (HK-2) cells. Biochem Biophys Res Commun 405: 68-73, 2011.
55. Yu YL, Chou RH, Wu CH, et al: Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776. J Biol Chem 287: 31015-31026, 2012.
56. Chen KH, Li PC, Lin WH, Chien CT and Low BH: Depression by a green tea extract of alcohol-induced oxidative stress and lipogenesis in rat liver. Biosci Biotechnol Biochem 75: 1668-1676, 2011.
57. Lin BR, Yu CJ, Chen WC, et al: Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling. J Biomed Sci 16: 35, 2009.
58. Yu YL, Yu SL, Su KJ, et al: Extended O6-methylguanine methyltransferase promoter hypermethylation following n-butylidenephthalide combined with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on inhibition of human hepatocellular carcinoma cell growth. J Agric Food Chem 58: 1630-1638, 2010.
59. Yu YL, Wei CW, Chen YL, Chen MH and Yiang GT: Immunotherapy of breast cancer by single delivery with rAAV2-mediated interleukin-15 expression. Int J Oncol 36: 365-370, 2010.
60. Yiang GT, Chen YH, Chou PL, Chang WJ, Wei CW and Yu YL: The NS3 protease and helicase domains of Japanese encephalitis virus trigger cell death via caspase-dependent and -independent pathways. Mol Med Rep 7: 826-830, 2013.
61. Yiang GT, Yu YL, Hu SC, Chen MH, Wang JJ and Wei CW: PKC and MEK pathways inhibit caspase-9/-3-mediated cytotoxicity in differentiated cells. FEBS Lett 582: 881-885, 2008.
62. Wei CW, Lin CC, Yu YL, et al: n-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2alpha and telomerase activity. Acta Pharmacol Sin 30: 1297-1306, 2009.
63. Hassane S, Leonhard WN, van der Wal A, et al: Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease. J Pathol 222: 21-31, 2010.
64. Edward M, Quinn JA, Mukherjee S, et al: Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 214: 584-593, 2008. (Pubitemid 351482273)
65. Kumari A and Kakkar P: Lupeol protects against acetaminophen-induced oxidative stress and cell death in rat primary hepatocytes. Food Chem Toxicol 50: 1781-1789, 2012.
66. Anoush M, Eghbal MA, Fathiazad F, Hamzeiy H and Kouzehkonani NS: The protective effects of garlic extract against acetaminophen-induced oxidative stress and glutathione depletion. Pak J Biol Sci 12: 765-771, 2009.
67. Yao Y, Yang J, Wang D, et al: The aqueous extract of Lycopus lucidus Turcz ameliorates streptozotocin-induced diabetic renal damage via inhibiting TGF-beta1 signaling pathway. Phytomedicine 20: 1160-1167, 2013.
68. Hsieh TJ, Hsieh PC, Tsai YH, et al: Melamine induces human renal proximal tubular cell injury via transforming growth factor-beta and oxidative stress. Toxicol Sci 130: 17-32, 2012.
69. Hills CE, Siamantouras E, Smith SW, Cockwell P, Liu KK and Squires PE: TGFβ modulates cell-to-cell communication in early epithelial-to- mesenchymal transition. Diabetologia 55: 812-824, 2012.
70. Xu Y, Yang S, Huang J, Ruan S, Zheng Z and Lin J: Tgf-β1 induces autophagy and promotes apoptosis in renal tubular epithelial cells. Int J Mol Med 29: 781-790, 2012.
71. Yoshikawa M, Hishikawa K, Idei M and Fujita T: Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells. Eur J Pharmacol 642: 28-36, 2010.
72. Li R, Wang Y, Liu Y, et al: Curcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cells. PLoS One 8: e58848, 2013.
73. Han WQ, Zhu Q, Hu J, Li PL, Zhang F and Li N: Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. Biochim Biophys Acta 1833: 1454-1462, 2013.
74. Yan HD, Li XZ, Xie JM and Li M: Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells. Chin Med J (Engl) 120: 787-793, 2007.
75. Guo W, Xu H, Huang WY, et al: Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1. Zhonghua Yi Xue Za Zhi 87: 1660-1665, 2007 (In Chinese). (Pubitemid 47316229)
76. Levanon D, Manov I and Iancu TC: Qualitative and quantitative analysis of the effects of acetaminophen and N-acetylcysteine on the surface morphology of Hep3B hepatoma cells in vitro. Ultrastruct Pathol 28: 3-14, 2004. (Pubitemid 38299719)
77. Williamson K, Wahl MS and Mycyk MB: Direct comparison of 20-hour IV, 36-hour oral, and 72-hour oral acetylcysteine for treatment of acute acetaminophen poisoning. Am J Ther 20: 37-40, 2013.
78. Saritas A, Kandis H, Baltaci D, et al: N-Acetyl cysteine and erdosteine treatment in acetaminophen-induced liver damage. Toxicol Ind Health: Oct 15, 2012 (Epub ahead of print).